SCHEMBL3700722

SCHEMBL3700722

O=C(NCC1CC1)c1nc2c(C(F)(F)F)cc(-c3ccco3)cn2c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
HDAC4 P56524 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
VCP P55072 1/20 0.36
CNR2 P34972 4/20 0.36
SCD5 Q86SK9 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3700869 0.96 ALDH1A1 (0.41) PKMRXFP1HDAC4HDAC6ALDH1A1
SCHEMBL7493610 0.95 CNR2 (0.43) PKMRXFP1CNR2CYP1A2CYP2C9
SCHEMBL3705906 0.88 HPGD (0.48) PKMALDH1A1MEN1KMT2AKDM4E
SCHEMBL3700188 0.88 HPGD (0.46) PKMALDH1A1MEN1KMT2AKDM4E
SCHEMBL7490436 0.86 ALDH1A1 (0.48) PKMRXFP1ALDH1A1MEN1KMT2A
SCHEMBL3696233 0.85 PKM (0.49) PKMRXFP1HDAC4HDAC6ALDH1A1
SCHEMBL3703771 0.84 SCD5 (0.47) PKMRXFP1MEN1KMT2AADORA2A
SCHEMBL3702560 0.83 ADORA2A (0.46) PKMRXFP1ALDH1A1MEN1KMT2A
SCHEMBL3684339 0.83 ALDH1A1 (0.48) PKMRXFP1HDAC4ALDH1A1MEN1
SCHEMBL7495068 0.83 PKM (0.46) PKMRXFP1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
WO-2009023179-A2 NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections OAT, HAVCR2, CPS1 PKM 2286/4885RXFP1 4676/4885HDAC4 1478/4885
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections OAT, HAVCR2, CPS1 PKM 2286/4885RXFP1 4676/4885HDAC4 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.